טוען...
Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review
BACKGROUND: As the popularity of long-acting reversible contraception increases, so does the need for accurate data on method continuation in diverse clinical settings. We determined 2-year continuation rates for the levonorgestrel 52-mg intrauterine device, the copper T380A intra-uterine device, an...
שמור ב:
| הוצא לאור ב: | Am J Obstet Gynecol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6040817/ https://ncbi.nlm.nih.gov/pubmed/28188772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2017.02.003 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|